Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/26/2012CA2819158A1 1,4 oxazines as bace1 and/or bace2 inhibitors
07/26/2012CA2818470A1 2-methoxy-pyridin-4-yl derivatives
07/26/2012CA2816094A1 Compounds and pharmaceutical compositions for uses in diabetes
07/26/2012CA2816093A1 Compounds and compositions for the treatment of cancer
07/25/2012EP2479280A1 Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid A (3D-MLA)
07/25/2012EP2479276A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
07/25/2012EP2479275A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
07/25/2012EP2479194A2 Method for manufacturing low molecular weight hyaluronic acid
07/25/2012EP2479183A2 Polymorphs of sarsasapogenin
07/25/2012EP2479177A1 Process for the preparation of antibiotic compounds
07/25/2012EP2479175A1 Compounds and methods for treating dyslipidemia
07/25/2012EP2479174A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
07/25/2012EP2479173A1 Therapeutic agents useful for treating pain
07/25/2012EP2479168A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists
07/25/2012EP2479165A1 Glycine compound
07/25/2012EP2478918A2 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
07/25/2012EP2478909A2 Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol
07/25/2012EP2478908A2 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
07/25/2012EP2478907A2 Methods and compositions for treating cancer
07/25/2012EP2478906A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
07/25/2012EP2478905A2 Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles
07/25/2012EP2478904A1 A pharmaceutical composition for peroral administration of diindolylmethane
07/25/2012EP2478903A1 Compositions comprising activators of PKC and inhibitors of PKC ubiquitination
07/25/2012EP2478902A1 Pharmaceutical composition for reducing weight and method for the production thereof
07/25/2012EP2478901A2 Neurogenic compounds
07/25/2012EP2478900A1 Monohydrate creatins intended for regulating the hormone secretions and infertility of the cycle, in vitro fertilisation and artificial insemination
07/25/2012EP2478899A1 Composition for alleviating ultraviolet radiation-induced damage
07/25/2012EP2478898A1 Method of regulating fertilizing ability using cyclic ADP-ribose and CD38
07/25/2012EP2478895A2 Compositions for treating esophageal disorders
07/25/2012EP2478894A2 Compositions for treating esophageal disorders
07/25/2012EP2478779A1 Composition for providing beneficial health effects
07/25/2012EP2478362A1 Use of the sparc microenvironment signature in the treatment of cancer
07/25/2012EP2478101A1 Fra-1 target genes as drug targets for treating cancer
07/25/2012EP2478099A1 Method and composition for treating alzheimer-type dementia
07/25/2012EP2477994A1 Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
07/25/2012EP2477993A1 Substituted clavulanic acid
07/25/2012EP2477990A1 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof
07/25/2012EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
07/25/2012EP2477988A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
07/25/2012EP2477987A1 Modulators of toll-like receptors
07/25/2012EP2477985A1 Treatment of cancer
07/25/2012EP2477984A1 A method for the n-demethylation of n-methyl heterocycles
07/25/2012EP2477983A1 (4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanone compounds and their use
07/25/2012EP2477982A2 Compounds that modulate intracellular calcium
07/25/2012EP2477981A1 Heterocyclic mglu5 antagonists
07/25/2012EP2477980A1 Hcv protease inhibitors
07/25/2012EP2477977A2 Treatment for oxidative stress and/or hypertension
07/25/2012EP2477976A1 Quinazolinone derivatives as viral polymerase inhibitors
07/25/2012EP2477975A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same
07/25/2012EP2477974A2 Nicotine haptens, immunoconjugates and their uses
07/25/2012EP2477972A1 Abt-263 crystalline forms and solvates for use in treating bcl-2 protein related diseases
07/25/2012EP2477969A1 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases
07/25/2012EP2477968A1 N- [2-hydroxycarbamoyl-2- (piperazinyl) ethyl]benzamide compounds, their preparation and their use as tace inhibitors
07/25/2012EP2477966A1 Processes and intermediates
07/25/2012EP2477965A1 Cosmetic composition including leucodopachrome derivative
07/25/2012EP2477963A1 Aryl sulphone derivatives as calcium channel blockers
07/25/2012EP2477960A1 Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol
07/25/2012EP2477700A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same
07/25/2012EP2477699A1 Medical use of spla2 hydrolysable liposomes
07/25/2012EP2477660A1 Pharmaceutical composition having the active substances metformin and sitagliptin or vildaliptin
07/25/2012EP2477656A1 Treatment of neurological conditions
07/25/2012EP2477642A1 Method of treating asthma with antiviral agents
07/25/2012EP2477641A2 Inhibition of endosomal toll-like receptor activation
07/25/2012EP2477634A1 Non-sedating antihistamine injection formulations and methods of use thereof
07/25/2012EP2477633A1 "dietary supplement stimulating the male sexual function"
07/25/2012EP2477632A1 Pharmaceutical combination for treating tumor
07/25/2012EP2477631A1 Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2477630A1 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2477629A1 Substituted heteroarylamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2477628A1 Preparation of crystalline forms of dihydropyrazolopyrimidinone
07/25/2012EP2477627A1 Use of opioid receptor antagonist for gastrointestinal tract disorders
07/25/2012EP2477626A2 Role of n-2 hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury
07/25/2012EP2477625A2 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
07/25/2012EP2477624A1 Compositions and methods for treating seizure disorders
07/25/2012EP2477623A1 Compositions and methods for treating disorders of gastrointestinal motility
07/25/2012EP2477622A1 Compositions and methods for treating spasticity
07/25/2012EP2477621A1 Lubiprostone for obstetrical or gynecological applications
07/25/2012EP2477620A1 Method of slowing the aging process by activating sirtuin enzymes with a combination of fucoxanthin and punicic acid
07/25/2012EP2477619A2 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria
07/25/2012EP2477618A2 Nutritional compositions including exogenous vitamin k2
07/25/2012EP2477616A2 Transdermal therapeutic system for administering fentanyl or an analogue thereof
07/25/2012EP2477615A2 Encapsulation using wax-type substances
07/25/2012EP2477611A1 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
07/25/2012EP2477610A1 A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti -inflammatory drug
07/25/2012EP2477609A1 Orally disintegrating pharmaceutical dosage form containing aripiprazole
07/25/2012EP2477608A1 Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
07/25/2012EP2477606A1 Rapidly soluble solid pharmaceutical preparations containing amphiphilic copolymers based on polyethers in combination with hydrophilic polymers
07/25/2012EP2477605A1 Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants
07/25/2012EP2477604A2 Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone
07/25/2012EP2477594A1 Isoketal scavengers and mitigation of disorders involving oxidative injury
07/25/2012EP2477510A1 Nutritional compositions for modulating inflammation including exogenous vitamin k2
07/25/2012EP2477496A1 Novel compounds and therapeutic use thereof for protein kinase inhibition
07/25/2012EP2477495A1 Tricyclic compounds and pharmaceutical uses thereof
07/25/2012EP2477494A1 Na/k-atpase ligands, ouabain antagonists, assays and uses thereof
07/25/2012EP2477492A1 Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/25/2012EP2349220B1 Using of organic solvents in wet granulation of moxifloxacin
07/25/2012EP2292611B1 Novel thiophenediamine derivative having urea structure
07/25/2012EP2280961B1 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
07/25/2012EP2220091B1 Reverse transcriptase inhibitors
07/25/2012EP2205558B1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
1 ... 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 ... 7860